LifeVantage (LFVN) Stock Chart & Stock Price History → CEO of Biggest AI Chipmaker Just Dropped a Bombshell… (From Banyan Hill Publishing) (Ad) Free LFVN Stock Alerts $7.00 +0.23 (+3.40%) (As of 05/14/2024 ET) Add Compare Share Share ChartStock AnalysisChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability LifeVantage Stock Price Performance5 Day Performance+4.48%1 Month Performance+21.74%3 Month Performance+7.86%6 Month Performance+49.25%Year-To-Date Performance+16.67%1 Year Performance+60.18% Receive LFVN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for LifeVantage and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Stocks NewsWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarRevolutionizing communication is what this NASDAQ-traded next-gen solution provider is doing. See how this company is well-positioned to capitalize in 2024 LFVN Stock Chart for Wednesday, May, 15, 2024 LFVN Chart by TradingView LifeVantage Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/14/2024$6.77$7.00+3.40%$7.01$6.7783,146 shs$88.90 million05/13/2024$6.70$6.77+1.04%$6.99$6.75117,693 shs$85.99 million05/10/2024$6.80$6.70-1.47%$6.94$6.7040,291 shs$85.10 million05/09/2024$6.64$6.80+2.41%$6.82$6.6417,764 shs$86.37 million05/08/2024$6.34$6.64+4.73%$6.89$6.3423,399 shs$84.34 million05/07/2024$6.77$6.34-6.35%$6.89$6.3439,173 shs$80.52 million Get the Latest News and Ratings for LFVN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for LifeVantage and its competitors with MarketBeat's FREE daily newsletter. 05/06/2024$6.57$6.77+3.04%$7.00$6.6885,733 shs$85.98 million05/03/2024$6.11$6.57+7.53%$6.57$6.0623,933 shs$84.54 million05/02/2024$6.18$6.11-1.13%$6.32$6.1023,849 shs$78.64 million05/01/2024$6.10$6.18+1.31%$6.24$6.118,916 shs$79.54 million04/30/2024$6.01$6.10+1.50%$6.17$5.9316,967 shs$78.51 million04/29/2024$6.19$6.01-2.83%$6.19$5.7630,251 shs$77.35 million04/26/2024$6.24$6.19-0.88%$6.41$6.0018,276 shs$79.60 million04/25/2024$6.17$6.24+1.13%$6.26$6.135,015 shs$80.31 million04/24/2024$6.41$6.17-3.67%$6.61$6.1018,252 shs$79.40 million04/23/2024$6.05$6.41+5.87%$6.47$6.0021,781 shs$82.43 million04/22/2024$6.70$6.05-9.70%$6.72$6.0342,786 shs$77.86 million04/19/2024$6.66$6.70+0.60%$6.99$6.6488,388 shs$86.22 million04/18/2024$6.60$6.66+0.91%$6.70$6.5723,350 shs$85.71 million04/17/2024$6.26$6.60+5.43%$6.61$6.1355,867 shs$84.94 million04/16/2024$5.75$6.26+8.87%$6.26$5.6650,299 shs$80.57 million04/15/2024$6.19$5.75-7.11%$6.19$5.7524,932 shs$74.00 million04/12/2024$6.08$6.19+1.81%$6.27$6.0812,152 shs$79.67 million04/11/2024$6.15$6.08-1.14%$6.31$6.0135,187 shs$78.25 million04/10/2024$6.12$6.15+0.49%$6.19$6.107,619 shs$79.15 million04/09/2024$6.14$6.12-0.33%$6.31$6.129,074 shs$78.76 million04/08/2024$6.20$6.14-0.97%$6.36$6.1422,794 shs$79.02 million04/05/2024$6.20$6.20+0.08%$6.25$6.0816,069 shs$79.78 million04/04/2024$6.14$6.20+0.90%$6.37$6.1717,980 shs$79.73 million04/03/2024$6.47$6.14-5.10%$6.46$6.0629,486 shs$79.02 million04/02/2024$6.39$6.47+1.25%$6.58$6.3322,863 shs$83.27 million04/01/2024$6.05$6.39+5.62%$6.45$5.8534,601 shs$82.24 million03/29/2024$6.05$6.05$6.50$5.8333,633 shs$77.86 million03/28/2024$6.21$6.05-2.58%$6.50$5.9133,633 shs$77.86 million03/27/2024$6.18$6.21+0.49%$6.27$6.1413,934 shs$79.92 million03/26/2024$6.27$6.18-1.44%$6.25$6.0637,939 shs$79.54 million03/25/2024$6.90$6.27-9.13%$6.82$6.2747,333 shs$80.68 million03/22/2024$6.93$6.90-0.43%$6.97$6.7013,131 shs$88.80 million03/21/2024$6.96$6.93-0.43%$7.00$6.9118,418 shs$89.19 million03/20/2024$6.95$6.96+0.14%$7.01$6.9111,194 shs$89.56 millionWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radar (Ad)Revolutionizing communication is what this NASDAQ-traded next-gen solution provider is doing. See how this company is well-positioned to capitalize in 202403/19/2024$6.92$6.95+0.43%$7.03$6.9228,535 shs$89.45 million03/18/2024$7.00$6.92-1.14%$7.05$6.8545,451 shs$89.06 million03/15/2024$6.89$7.00+1.60%$7.00$6.8527,250 shs$90.08 million03/14/2024$6.84$6.89+0.73%$6.99$6.8626,746 shs$88.67 million03/13/2024$6.88$6.84-0.58%$6.95$6.8025,890 shs$88.03 million03/12/2024$6.93$6.88-0.72%$7.04$6.8739,142 shs$88.55 million03/11/2024$6.95$6.93-0.22%$7.02$6.8040,374 shs$89.19 million03/08/2024$6.90$6.95+0.65%$7.03$6.9031,159 shs$89.38 million03/07/2024$6.96$6.90-0.86%$7.02$6.9031,900 shs$88.80 million03/06/2024$7.00$6.96-0.57%$7.05$6.9639,388 shs$89.56 million03/05/2024$6.93$7.00+1.01%$7.08$6.9141,691 shs$90.09 million03/04/2024$7.00$6.93-1.00%$7.05$6.9057,408 shs$89.19 million03/01/2024$6.82$7.00+2.64%$7.05$6.8547,679 shs$90.08 million02/29/2024$7.01$6.82-2.71%$7.03$6.8036,405 shs$87.77 million02/28/2024$6.87$7.01+2.04%$7.01$6.8335,598 shs$90.22 million02/27/2024$6.98$6.87-1.58%$7.00$6.8338,278 shs$88.42 million02/26/2024$6.73$6.98+3.71%$7.01$6.6348,626 shs$89.83 million02/23/2024$6.81$6.73-1.17%$7.01$6.6037,800 shs$86.62 million02/22/2024$6.98$6.81-2.44%$7.09$6.8136,053 shs$87.65 million02/21/2024$6.92$6.98+0.87%$7.06$6.8639,967 shs$89.82 million02/20/2024$6.85$6.92+1.02%$7.12$6.8040,207 shs$89.06 million02/19/2024$6.85$6.85$7.23$6.46113,200 shs$88.16 million02/16/2024$6.49$6.85+5.55%$7.23$6.46113,270 shs$88.16 million02/15/2024$6.43$6.49+0.93%$6.55$6.1758,854 shs$83.53 million02/14/2024$6.26$6.43+2.72%$6.72$6.2571,366 shs$82.75 million Related Companies: Tempest Therapeutics Stock Chart Affimed Stock Chart Hookipa Pharma Stock Chart Jaguar Health Stock Chart Corvus Pharmaceuticals Stock Chart Leap Therapeutics Stock Chart Reviva Pharmaceuticals Stock Chart Anebulo Pharmaceuticals Stock Chart Connect Biopharma Stock Chart SELLAS Life Sciences Group Stock Chart Receive LFVN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for LifeVantage and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:LFVN) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaForget the “Magnificent 7” Tech Companies, Buy This AI Stock InsteadBanyan Hill PublishingWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market InsidersGold Set to EXPLODE!Gold Safe ExchangeCharles Payne Demystifies OptionsUnstoppable ProsperityBiden to Drop BOMBSHELL June 13th?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LifeVantage Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.